Genetic Signatures Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.03 |
Market Cap |
AUD118.6 M |
Shares Outstanding |
104.03 M |
Public Float |
51.67 M |
Address |
7 Eliza Street Newtown New South Wales (NSW) 2042 Australia |
Employees | - |
Website | http://www.geneticsignatures.com |
Updated | 07/08/2019 |
Genetic Signatures Ltd. engages in the research and commercialization of identifying individual genetic signatures to identify diseases and disabilities. Its molecular diagnostics, 3Base, provides high-volume hospital and pathology laboratories the ability to screen wide array of infectious pathogens. The firm also designs and manufactures suite of real-time polymerase chain reaction based products for the routine detection of infectious diseases under the EasyScreen brand. |